跳转至内容
Merck

1148090

USP

胶原酶 II

United States Pharmacopeia (USP) Reference Standard

别名:

胶原酶 来源于溶组织梭菌, 梭菌肽酶 A

登录查看公司和协议定价


About This Item

CAS号:
MDL號碼:
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

pharmaceutical primary standard

製造商/商標名

USP

應用

pharmaceutical

格式

neat

儲存溫度

−70°C

正在寻找类似产品? 访问 产品对比指南

一般說明

胶原蛋白酶II是一种金属蛋白酶,起内肽酶作用,并表现出三肽羧肽酶活性。显示内肽酶活性时,主要裂解位点位于人类胶原蛋白双链氨基酸甘氨酸-脯氨酸之前。水解发生在胶原蛋白三螺旋区域的内部。胶原蛋白酶II也被称为II类胶原蛋白酶,包含三种亚型:δ、ε和ζ。 胶原蛋白酶II USP参考标准按现行药典规定交付。所有为支持本产品而提供的信息,包括MSDS和任何产品信息单均由药典颁发机构制定并发布。如需进一步信息和支持,请访问现行药典网站。

應用


  • Collagenase Type II for Enhanced Cell Isolation in Biomedical Research: Collagenase Type II is extensively applied in tissue dissociation for isolating cells, crucial for regenerative medicine and tissue engineering. It enables efficient breakdown of the extracellular matrix, facilitating easier cell extraction and purification for use in 3D cell culture and stem cell research. This enzymatic method is invaluable for studies requiring high-purity cell populations, making it indispensable in developing therapies for diseases like Parkinson′s and Alzheimer′s (Park et al., 2024).

  • Advancing Tissue Engineering with Collagenase II: In tissue engineering, Collagenase II plays a pivotal role by degrading the collagen matrix in tissues, thereby enabling the cultivation of cells in a controlled environment. This process is essential for constructing tissue structures from the ground up, particularly in developing organoids that mimic natural organ functionalities. The use of high-grade biotech collagenase ensures reproducibility and effectiveness in these sophisticated applications (Wu et al., 2024).

  • Collagenase II in 3D Cell Culture Systems: Collagenase II is instrumental in preparing extracellular matrices for 3D cell cultures, which are critical for studying cell behaviors in environments that closely replicate in vivo conditions. This enzyme helps in the accurate study of cellular interactions and pharmacological responses, providing a more realistic assessment of cellular dynamics in medical research (Jiang et al., 2024).

  • Role of Collagenase II in Stem Cell Research: Utilizing Collagenase II in stem cell research enhances the isolation and maintenance of stem cells. This is particularly important for applications where the integrity and viability of stem cells are crucial, such as in regenerative medicine and therapeutic cloning. The enzyme′s ability to gently dissociate cells while preserving their functionality makes it a staple in cutting-edge biomedical research (Simón-Pérez et al., 2024).

  • Collagenase II for Effective Extracellular Matrix Degradation: The ability of Collagenase II to efficiently degrade collagen-rich extracellular matrices is utilized in various biomedical applications, including cancer research where it aids in tumor microenvironment studies and drug penetration analyses. This enzymatic activity is crucial for understanding the interactions between cancer cells and their surrounding stroma, providing insights into potential therapeutic targets (Mohamed et al., 2024).

生化/生理作用

每摩尔胶原蛋白酶被4g原子钙活化。 它被乙二醇-双(β-氨基乙基醚)-N,NN′,N′-四乙酸,β-巯基乙醇、谷胱甘肽、巯基乙酸和8-羟基喹啉抑制。

單位定義

一个胶原蛋白消化单元(CDU)从牛跟腱胶原蛋白中释放的肽链量和1.0 μ亮氨酸,5小时,pH7.4,37℃,在钙离子存在下的茚三酮颜色相同。一个 FALGPA水解单元每分钟,25℃,水解1.0 μmole 呋喃基丙烯酰-Leu-Gly-Pro-Ala。一个中性蛋白酶单元水解酪蛋白,产生颜色和1.0 μmole 酪氨酸每5小时,pH7.5,37℃下产生的相同。一个梭菌蛋白酶单元在DTT存在下,pH7.6,25℃,每分钟水解1.0 μmole BAEE。

分析報告

这些产品仅供测试和化验使用。它们不适用于人类或动物,也不能用于诊断、治疗或治愈任何类型的疾病。

其他說明

This product is part of the USP Biologics program.

象形圖

Health hazard

訊號詞

Danger

危險聲明

防範說明

危險分類

Resp. Sens. 1

儲存類別代碼

12 - Non Combustible Liquids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Yasin Emre Kaya et al.
Turkish neurosurgery, 30(3), 434-441 (2020-04-03)
To investigate the effects of metformin, a drug used widely for the treatment of type 2 diabetes mellitus, on human primary cell cultures prepared from uninjured segment of disc material intervertebral disk tissues. Primary cell cultures were prepared using the
Michalis Mastri et al.
American journal of clinical and experimental urology, 9(6), 416-434 (2022-01-08)
The evolving paradigm of the molecular classification of bladder cancer requires models that represent the classifications with less heterogeneity. Robust transcriptome based molecular classifications are essential to address tumor heterogeneity. Patient derived models (PDMs) are a powerful preclinical tool to

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门